Human Genome Epidemiology Literature Finder
Records 1 - 2 (of 2 Records) |
Query Trace: Appetite and BRCA1[original query] |
---|
Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study. The Lancet. Oncology 2011 Sep 12 (9): 852-61. Gelmon Karen A, Tischkowitz Marc, Mackay Helen, Swenerton Kenneth, Robidoux André, Tonkin Katia, Hirte Hal, Huntsman David, Clemons Mark, Gilks Blake, Yerushalmi Rinat, Macpherson Euan, Carmichael James, Oza Am |
A phase 1 study of PARP-inhibitor ABT-767 in advanced solid tumors with BRCA1/2 mutations and high-grade serous ovarian, fallopian tube, or primary peritoneal cancer. Investigational new drugs 2018 1 36 (5): 828-835. van der Biessen Diane A J, Gietema Jourik A, de Jonge Maja J A, Desar Ingrid M E, den Hollander Martha W, Dudley Matthew, Dunbar Martin, Hetman Robert, Serpenti Camille, Xiong Hao, Mittapalli Rajendar K, Timms Kirsten M, Ansell Peter, Ratajczak Christine K, Shepherd Stacie Peacock, van Herpen Carla M |
- Page last reviewed:Oct 1, 2023
- Page last updated:Dec 01, 2023
- Content source: